
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5075238
[patent_doc_number] => 20070015213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Peptide arrays and methods of preparation'
[patent_app_type] => utility
[patent_app_number] => 11/487062
[patent_app_country] => US
[patent_app_date] => 2006-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15728
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015213.pdf
[firstpage_image] =>[orig_patent_app_number] => 11487062
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/487062 | Peptide arrays and methods of preparation | Jul 12, 2006 | Issued |
Array
(
[id] => 5480624
[patent_doc_number] => 20090203581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Novel Peptides for Use in the Treatment of Obesity'
[patent_app_type] => utility
[patent_app_number] => 11/995351
[patent_app_country] => US
[patent_app_date] => 2006-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21056
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203581.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995351
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995351 | Novel Peptides for Use in the Treatment of Obesity | Jul 6, 2006 | Abandoned |
Array
(
[id] => 5113855
[patent_doc_number] => 20070197771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Methods for the synthesis of two or more dicarba bridges in organic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/480114
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 54559
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197771.pdf
[firstpage_image] =>[orig_patent_app_number] => 11480114
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/480114 | Methods for the synthesis of two or more dicarba bridges in organic compounds | Jun 29, 2006 | Issued |
Array
(
[id] => 82183
[patent_doc_number] => 07745573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides'
[patent_app_type] => utility
[patent_app_number] => 11/480018
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 54647
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745573.pdf
[firstpage_image] =>[orig_patent_app_number] => 11480018
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/480018 | Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides | Jun 29, 2006 | Issued |
Array
(
[id] => 5242844
[patent_doc_number] => 20070021339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'GLP-1 pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/479074
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12433
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021339.pdf
[firstpage_image] =>[orig_patent_app_number] => 11479074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/479074 | GLP-1 pharmaceutical compositions | Jun 29, 2006 | Issued |
Array
(
[id] => 4950120
[patent_doc_number] => 20080306246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Process for Attaching Effector Molecules to Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/994053
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7782
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306246.pdf
[firstpage_image] =>[orig_patent_app_number] => 11994053
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/994053 | Process for attaching effector molecules to proteins | Jun 28, 2006 | Issued |
Array
(
[id] => 5662096
[patent_doc_number] => 20060252692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Inhibitors for use in hemostasis'
[patent_app_type] => utility
[patent_app_number] => 11/479928
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22614
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252692.pdf
[firstpage_image] =>[orig_patent_app_number] => 11479928
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/479928 | Inhibitors for use in hemostasis | Jun 28, 2006 | Abandoned |
Array
(
[id] => 833635
[patent_doc_number] => 07396925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-08
[patent_title] => 'Volatilizable solid phase supports for compound synthesis'
[patent_app_type] => utility
[patent_app_number] => 11/474671
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3444
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/396/07396925.pdf
[firstpage_image] =>[orig_patent_app_number] => 11474671
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/474671 | Volatilizable solid phase supports for compound synthesis | Jun 25, 2006 | Issued |
Array
(
[id] => 4644105
[patent_doc_number] => 08021709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Systems and methods for separating proteins from connective tissue'
[patent_app_type] => utility
[patent_app_number] => 11/994350
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 11038
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/021/08021709.pdf
[firstpage_image] =>[orig_patent_app_number] => 11994350
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/994350 | Systems and methods for separating proteins from connective tissue | Jun 25, 2006 | Issued |
Array
(
[id] => 6445995
[patent_doc_number] => 20100279925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'Airway Administration of Site-Inactived FVIIA in Inflammatory Conditions Affecting the Respiratory Tract'
[patent_app_type] => utility
[patent_app_number] => 11/993264
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8236
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279925.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993264
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993264 | Airway Administration of Site-Inactived FVIIA in Inflammatory Conditions Affecting the Respiratory Tract | Jun 22, 2006 | Abandoned |
Array
(
[id] => 5000322
[patent_doc_number] => 20070042956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Novel GLP-1 compounds'
[patent_app_type] => utility
[patent_app_number] => 11/454804
[patent_app_country] => US
[patent_app_date] => 2006-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34190
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042956.pdf
[firstpage_image] =>[orig_patent_app_number] => 11454804
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/454804 | Novel GLP-1 compounds | Jun 15, 2006 | Abandoned |
Array
(
[id] => 5859781
[patent_doc_number] => 20060229253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Pentapeptide compounds and uses related thereto'
[patent_app_type] => utility
[patent_app_number] => 11/451147
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32798
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229253.pdf
[firstpage_image] =>[orig_patent_app_number] => 11451147
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/451147 | Pentapeptide compounds and uses related thereto | Jun 11, 2006 | Issued |
Array
(
[id] => 8006419
[patent_doc_number] => 08084610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-27
[patent_title] => 'Compositions and methods for detecting and treating tumors containing acidic areas'
[patent_app_type] => utility
[patent_app_number] => 11/449495
[patent_app_country] => US
[patent_app_date] => 2006-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 31
[patent_no_of_words] => 26211
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/084/08084610.pdf
[firstpage_image] =>[orig_patent_app_number] => 11449495
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/449495 | Compositions and methods for detecting and treating tumors containing acidic areas | Jun 6, 2006 | Issued |
Array
(
[id] => 330543
[patent_doc_number] => 07511039
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-31
[patent_title] => 'β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins'
[patent_app_type] => utility
[patent_app_number] => 11/448412
[patent_app_country] => US
[patent_app_date] => 2006-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 24797
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/511/07511039.pdf
[firstpage_image] =>[orig_patent_app_number] => 11448412
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/448412 | β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins | Jun 6, 2006 | Issued |
Array
(
[id] => 5688932
[patent_doc_number] => 20060287247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Halogen-substituted thienyl compounds'
[patent_app_type] => utility
[patent_app_number] => 11/446598
[patent_app_country] => US
[patent_app_date] => 2006-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14253
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287247.pdf
[firstpage_image] =>[orig_patent_app_number] => 11446598
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/446598 | Halogen-substituted thienyl compounds | Jun 1, 2006 | Issued |
Array
(
[id] => 5643234
[patent_doc_number] => 20060281689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period'
[patent_app_type] => utility
[patent_app_number] => 11/443817
[patent_app_country] => US
[patent_app_date] => 2006-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 36557
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281689.pdf
[firstpage_image] =>[orig_patent_app_number] => 11443817
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/443817 | Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period | May 30, 2006 | Abandoned |
Array
(
[id] => 5337883
[patent_doc_number] => 20090054347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'KININ B1 RECEPTOR PEPTIDE AGONISTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/916136
[patent_app_country] => US
[patent_app_date] => 2006-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5025
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054347.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916136
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916136 | Kinin B1 receptor peptide agonists and uses thereof | May 30, 2006 | Issued |
Array
(
[id] => 5688933
[patent_doc_number] => 20060287248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Asymmetric dosing methods'
[patent_app_type] => utility
[patent_app_number] => 11/443887
[patent_app_country] => US
[patent_app_date] => 2006-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 42388
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287248.pdf
[firstpage_image] =>[orig_patent_app_number] => 11443887
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/443887 | Asymmetric dosing methods | May 30, 2006 | Abandoned |
Array
(
[id] => 5700628
[patent_doc_number] => 20060217313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => '5-CNAC as oral delivery agent for parathyroid hormone fragments'
[patent_app_type] => utility
[patent_app_number] => 11/443528
[patent_app_country] => US
[patent_app_date] => 2006-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3142
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217313.pdf
[firstpage_image] =>[orig_patent_app_number] => 11443528
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/443528 | 5-CNAC as oral delivery agent for parathyroid hormone fragments | May 29, 2006 | Abandoned |
Array
(
[id] => 5688929
[patent_doc_number] => 20060287244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'L-Threonine derivatives of high therapeutic index'
[patent_app_type] => utility
[patent_app_number] => 11/442027
[patent_app_country] => US
[patent_app_date] => 2006-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 34554
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287244.pdf
[firstpage_image] =>[orig_patent_app_number] => 11442027
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/442027 | L-Threonine derivatives of high therapeutic index | May 25, 2006 | Issued |